Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
iRadimed Corporation (IRMD) had Cash Flow from Financial Activities of $-6.73M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$21.20M |
|
$5.58M |
|
$4.71M |
|
$16.49M |
|
$14.37M |
|
$6.83M |
|
$0.46M |
|
$7.30M |
|
$7.30M |
|
$5.58M |
|
$5.58M |
|
$5.58M |
|
$5.58M |
|
$6.83M |
|
$7.22M |
|
12.72M |
|
12.86M |
|
$0.44 |
|
$0.43 |
|
| Balance Sheet Financials | |
$84.92M |
|
$23.79M |
|
$29.80M |
|
$114.72M |
|
$12.80M |
|
-- |
|
$3.57M |
|
$16.37M |
|
$98.35M |
|
$94.98M |
|
$98.35M |
|
12.72M |
|
| Cash Flow Statement Financials | |
$19.02M |
|
$-8.00M |
|
|
Cash Flow from Financial Activities |
$-6.73M |
$52.23M |
|
$56.53M |
|
$4.29M |
|
$2.22M |
|
$-6.49M |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
77.80% |
|
32.23% |
|
32.23% |
|
-- |
|
34.42% |
|
26.30% |
|
$11.02M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.40 |
|
1.53 |
|
58.83 |
|
5.67% |
|
5.87% |
|
4.86% |
|
5.67% |
|
$7.73 |
|
$0.86 |
|
$1.48 |
|